Lopez-Marfil, Marta https://orcid.org/0000-0001-5431-6447
Wang, Xichi
Lopez-Cantu, Diana Ofelia https://orcid.org/0000-0002-1949-0762
Pelayo-Minero, Leonardo Gael
Ebergenyi-Camarena, Andres
Colunga-Minutti, Jocelynn
Esquivel-Herrera, Antonio https://orcid.org/0000-0002-0443-7432
Zheng, Xiaozhang
Campbell, Veronica
Weiss, Matthew
Mainolfi, Nello
Slavin, Anthony
Lemos, Dario Ruben https://orcid.org/0000-0003-4493-2128
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124301)
Brigham and Women's Hospital (Brigham Research Institute Research Excellence Award)
Article History
Received: 9 November 2023
Accepted: 6 May 2026
First Online: 25 May 2026
Competing interests
: The authors declare the following competing interests: Campbell V., Zheng X., Weiss M., Mainolfi N. and Slavin A. are employees of Kymera Therapeutics. All other authors declare no competing interests.